JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hague, C.
Right arrow Articles by Abel, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hague, C.
Right arrow Articles by Abel, P. W.

Vol. 303, Issue 1, 403-411, October 2002

Relationship between alpha 1-Adrenergic Receptor-Induced Contraction and Extracellular Signal-Regulated Kinase Activation in the Bovine Inferior Alveolar Artery

Chris Hague, Pedro J. Gonzalez-Cabrera, William B. Jeffries and Peter W. Abel

Department of Pharmacology, Creighton University School of Medicine, Omaha, Nebraska

The endogenous adrenergic agonists norepinephrine (NE) and epinephrine regulate vascular tone by stimulating alpha 1-adrenergic receptors (ARs) on smooth muscle cells to cause contraction. In addition, alpha 1-ARs also couple to growth factor pathways, through stimulation of mitogen-activated protein kinases (MAPKs). MAPKs are a family of serine-threonine kinases that include extracellular signal-regulated kinase (ERK) and a variety of other kinases that are able to activate transcription factors when stimulated. We examined alpha 1-AR stimulation of contraction and ERK activation in the bovine inferior alveolar artery (BIAA), using in vitro contraction studies and Western blotting. Using antagonists selective for individual adrenergic receptor types, we found that only alpha 1-ARs were coupled to ERK activation and contraction. NE stimulated contraction (EC50 = 11 µM) and ERK activation (EC50 = 21 µM) with similar potency. Using alpha 1-AR subtype-selective antagonists, we identified the alpha 1-AR subtypes coupled to each response. Affinity values for alpha 1-AR subtype-selective antagonists were consistent with alpha 1A-AR-mediated contraction. In contrast, simultaneous treatment with concentrations of these antagonists selective for each alpha 1-AR subtype (alpha 1A-, alpha 1B-, and alpha 1D-AR) was required to inhibit ERK activation, suggesting that all three alpha 1-ARs activate ERK in BIAA. Transmural electrical stimulation of BIAA segments resulted in activation of ERK, which was inhibited by the alpha 1-AR-selective antagonist BE 2254 (2-[[beta -(4-hydroxyphenyl)ethyl]aminomethyl]-1-tetralone). These data suggest that in an intact artery, NE released from sympathetic nerves stimulates alpha 1-ARs to cause contraction and ERK activation, and that redundancy among subtypes exists for alpha 1-AR activation of ERK.


0022-3565/02/3031-0403$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
S. M. Summers, Y. Hayashi, S. V. Nguyen, T. M. Nguyen, and R. E. Purdy
Hindlimb unweighting induces changes in the p38MAPK contractile pathway of the rat abdominal aorta
J Appl Physiol, July 1, 2009; 107(1): 121 - 127.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Erami, H. Zhang, A. Tanoue, G. Tsujimoto, S. A. Thomas, and J. E. Faber
Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H744 - H753.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Zhang, D. Chalothorn, L. F. Jackson, D. C. Lee, and J. E. Faber
Transactivation of Epidermal Growth Factor Receptor Mediates Catecholamine-Induced Growth of Vascular Smooth Muscle
Circ. Res., November 12, 2004; 95(10): 989 - 997.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Zhang, S. Cotecchia, S. A. Thomas, A. Tanoue, G. Tsujimoto, and J. E. Faber
Gene deletion of dopamine {beta}-hydroxylase and {alpha}1-adrenoceptors demonstrates involvement of catecholamines in vascular remodeling
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2106 - H2114.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.